Intravitreal bevacizumab to treat acute central serous chorioretinopathy: Short-term effect

Ophthalmologica

Volumn 223, Issue 5, 2009, Pages 343-347

  Seong, Hyun Kyung ^a   Bae, Ji Hyun ^b   Kim, Eung Suk ^c   Han, Jae Ryong ^b   Nam, Woo Ho ^b   Kim, Ha Kyoung ^b  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

Central serous chorioretinopathy; Intravitreal bevacizumab (Avastin)

Indexed keywords

BEVACIZUMAB; FLUORESCEIN;

ADULT; ARTICLE; BLURRED VISION; CENTRAL SCOTOMA; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; FEMALE; HUMAN; INFORMED CONSENT; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RETINA EXAMINATION; SHORT COURSE THERAPY; SOMATOSENSORY CORTEX; TREATMENT DURATION; VISUAL ACUITY; VISUAL DISORDER; WILCOXON SIGNED RANKS TEST;

ACUTE DISEASE; ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 66749165278     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224782     Document Type: Article

References (33)

1. Hayashi K, Hasegawa Y, Tokoro T: Indocya-nine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986; 9: 37-41.
2. Prünte C: Indocyanine green angiography findings in central serous chorioretinopathy. Int Ophthalmol 1995; 19: 77-82.
3. Prünte C, Flammer J: Choroidal capillary and venous congestion in central serous cho-rioretinopathy. Am J Ophthalmol 1996; 121: 26-34.
4. Stanga PE, Lim JI, Hamilton P: Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003; 110: 15-21.
5. Piccolino FC, Borgia L: Central serous cho-rioretinopathy and indocyanine green angi-ography. Retina 1994; 14: 231-242.
6. Piccolino FC, Borgia L, Zinicola E, Zingirian M: Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995; 9: 324-332.
7. Slakter JS, Yannuzzi LA, Guyer DR, Sorenson JA, Orlock DA: Indocyanine-green angi-ography. Curr Opin Ophthalmol 1995; 6: 25-32.
8. Spaide RF, Hall L, Haas A, Campeas L, Yan-nuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA: Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996; 16: 203-213.
9. Yuzawa M, Kawamura A, Yamaguchi C, Shouda M, Shimoji M, Matsui M: Indocya-nine green videoangiographic findings in detachment of the retinal pigment epitheli-um. Ophthalmology 1995; 102: 622-629.
10. Guyer DR, Yannuzzi LA, Slakter JS, et al.: Digital indocyanine green videoangiogra-phy of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057-1062.
11. Menchini U, Virgili G, Lanzetta P, Ferrari E: Indocyanine green angiography in central serous chorioretinopathy. Int Ophthalmol 1997; 21: 57-69.
12. Uyama M, Matsunaga H, Matsubara T, Fukushima I, Takahashi K, Nishimura T: Indocyanine green angiography and pathophysi-ology of multifocal posterior pigment epitheliopathy. Retina 1999; 19: 12-21.
13. Constantinides G: Relation between retinal pigment epithelial detachment and dye leakage in central serous retinopathy. J Fr Oph-talmol 2000; 23: 649-654.
14. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A: Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288-289.
15. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D: Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057-1062.
16. Iida T, Hagimura N, Otani T, Ikeda F, Mu-raoka K: Choroidal vascular lesions in serous retinal detachment viewed with indocya-nine green angiography. Nippon Ganka Gak-kai Zasshi 1996; 100: 817-824.
17. Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504.
18. Niegel MF, Schrage NF, Christmann S, De-genring RF: Intravitreal bevacizumab for chronic central serous chorioretinopathy (in German). Ophthalmologe 2008; 105: 943-945.
19. Wang MS, Sander B, Larsen M: Retinal atrophy in idiopathic central serous chorioreti-nopathy. Am J Ophthalmol 2002; 133: 787-793.
20. Fuhrmeister H: A long-term study of morphological and functional developments after central serous chorioretinitis. Klin Mo-natsbl Augenheilkd 1983; 182: 549-551.
21. Wang M, Sander B, la Cour M, Larsen M: Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 2005; 83: 691-696.
22. Ober MD, Yannuzzi LA, Do DV, et al.: Photo-dynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005; 112: 2088-2094.
23. Pikkel J, Beiran I, Ophir A, Miler B: Acet-azolamide for central serous retinopathy. Ophthalmology 2002; 109: 1723-1725.
24. Burumcek E, Mudun A, Karacorlu S, et al.: Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997; 104: 616-622.
25. Canakis C, Conway MD, Livir-Rallatos C, et al.: Ocular photodynamic therapy in choroi-dal neovascularization complicating idiopathic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2004; 35: 168-171.
26. Canakis C, Livir-Rallatos C, Panayiotis Z, et al.: Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Oph-thalmol 2003; 136: 750-752.
27. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM: Pho-todynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23: 752-763.
28. Valmaggia C, Niederberger H: Photody-namic therapy in the treatment of chronic central serous chorioretinopathy. Klin Mo-natsbl Augenheilkd 2006; 223: 372-375.
29. Chan WM, Lam DS, Lai TY, et al.: Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 2003; 136: 836-845.
30. Yannuzzi LA, Slakter JS, Gross NE, et al.: In-docyanine green angiography-guided pho-todynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288-298.
31. Penha FM, Aggio FB, Bonomo PP: Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy. Am J Ophthalmol 2007; 143: 887-889.
32. Kanyange ML, De Laey JJ: Long-term follow-up of central serous chorioretinopathy (CSCR). Bull Soc Belge Ophtalmol 2002; 284: 39-44.
33. Mennel S, Peter S, Meyer CH, et al.: Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1015-1021.